Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
Medication-induced QT-interval prolongation and torsades de pointes: A turning point?
+Practice
In print
PHARMACOTHERAPY
Medication-induced QT-interval prolongation and torsades de pointes: A turning point?
Wednesday 15 July 2020, 01:15 AM

Drug interactions can increase the risk of QTinterval prolongation
Medication-induced QT-interval prolongation is a serious issue because it can lead to potentially fatal torsades de pointes. This article reviews how you can assess the risk and avoid the problem in your patients
Pauline McQuoid
Key points, Medications are the most common cause of acquired QT-interval prolongation, which increases the risk of developing torsades de pointes.
Many medical, Pract Green w Pale Yellow
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.